Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2016-Nov

Risk Factors for Post Endoscopic Retrograde Cholangiopancreatography Cholangitis

Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Veza se sprema u međuspremnik
Thana Boonsinsukh
Vichit Viriyaroj
Hariruk Yodying

Ključne riječi

Sažetak

Cholangitis is the one of complications in post endoscopic retrograde cholangiopancreatography (post- ERCP). Few studies investigated risk factors for post-ERCP cholangitis and the results showed different outcomes.

The aim of the study was to determine the contributing risk factors for post-ERCP cholangitis.

The medical records of patients who underwent ERCP from January 2013 to December 2015 were retrospectively reviewed. We excluded patients who had cholangitis before ERCP. All patients received intravenous prophylaxis antibiotic before the procedure. Demographic data, interested factors and result were collected. Univariate and multivariate analysis were used to identify risk factor for post-ERCP cholangitis.

227 patients enrolled where 204 (89.9%) of them were receiving therapeutic procedure. 156 (68.7%) patients were performed by high experience endoscopists (performing >50 ERCPs per year). The success rate was 87.7%. Post-ERCP cholangitis occurred in 20 (8.8%) patients as a result of therapeutic procedures. By univariate analysis, 8 variables were identified. They were male sex, age >60 year, no epigastric pain, albumin <2.5 gm/dL, bile duct cancer, common bile duct stones, change and remove bile duct stent. Multivariate analysis showed that age >60 year, albumin <2.5 gm/dL and remove bile duct stent were significantly associated with post-ERCP cholangitis.

Age >60 year, albumin <2.5 gm/dL and remove bile duct stent are three major risk factors for post-ERCP cholangitis.

Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta naukom

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti naukom
  • Prepoznavanje biljaka po slici
  • Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
  • Pročitajte naučne publikacije povezane sa vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima

Google Play badgeApp Store badge